About Otsuka
Our Leadership
Our board members and statutory auditors
Tatsuo Higuchi | Chairman and Representative Director |
---|---|
Makoto Inoue | President and Representative Director |
Yoshiro Matsuo | Executive Deputy President and Representative Director |
Susumu Tamai | Vice Chairman |
Kabir Nath | Senior Managing Director (Pharmaceutical Business) |
Mikio Bando | Managing Director (Emerging Countries and OIAA Division*) |
Shuichi Takagi | Managing Director (Business Strategy; concurrently President, Otsuka America, Inc.) |
Toshiki Sudo | Executive Director (Research and Intellectual Property) |
Shinichi Taira | Executive Director (OIAA Division*, Production) |
Akemi Kaneko | Executive Director (Quality Control and Quality Assurance) |
Kiyoshi Taniguchi | Executive Director (Production , Supply Chain and CMC) |
Yuko Makino | Executive Director (Finance) |
Ichiro Otsuka | Executive Director |
Nobuo Kouno | Standing Audit & Supervisory Board Member |
---|---|
Kazuya Inagaki | Standing Audit & Supervisory Board Member |
Takeo Suzuki | Standing Audit & Supervisory Board Member |
Hiroshi Sugawara | Audit & Supervisory Board Member |
* Otsuka International Asia Arab Division
As of March 9, 2022
Our corporate officers
Lyo Inuyama | Executive Vice President, Director (Medical Affairs) | Pharmaceutical Business Division |
---|---|---|
Keiso Yamasaki | Senior Vice President, Associate General Manager (Pharmaceutical Business Division), and Pharmaceutical Planning Department | |
Hiroaki Ono | Senior Vice President, General Manager (Headquarters of Clinical Development) and Regulatory Affairs | |
Akio Oikawa | Senior Vice President, General Manager (Pharmaceutical Business Headquarters) | |
Nobuyuki Kurahashi | Senior Vice President, Seconded to Otsuka Pharmaceutical D&C Inc. | |
Chikako Usami | Vice President, Pharmaceutical Business Division Project Coordinator | |
Takayuki Shiratsuchi | Vice President, Medical Discovery & Development Data Analyst (MD Analyst) | |
Naoshi Satou | Senior Vice President, Associate General Manager (Nutraceuticals Division), Director (Social Health Relations Department) and Director (Promotion Advertisement) | Nutraceuticals Division |
Chiaki Sakurai | Senior Vice President, Associate General Manager (Nutraceuticals Division), Sales Headquarters, Cosmedics Department and Otsuka Holdings | |
Shouzou Yamazaki | Senior Vice President, Director (Sales Development Department) | |
Taro Mikuriya | Senior Vice President, Seconded to Nardobel SAS | |
Tomonari Kawakami | Vice President, Director (Business Planning, Market Research & Education) | |
Tomitsugu Nakabayashi | Vice President, Next-Generation Nutraceuticals Business Solution | |
Koichiro Nitta | Vice President, Relational Marketing | |
Ryousuke Fukase | Vice President, Nutraceuticals Business | Otsuka International Asia Arab Division |
Yoshihiro Bando | Vice President, New Area Development | |
Toshihiro Tokumoto | Senior Vice President, Tokushima Headquarters, Purchasing and Otsuka Holdings | Productions |
Ryo Harima | Vice President, Deputy General Manager (Production) | |
Junichi Jinno | Vice President, General Manager (CMC) | |
Kenji Bunya | Senior Vice President, Director (Human Resources Department), Public Relations and Legal Affairs | Headquarters |
Junichi Hashimoto | Vice President, Director (Compliance), PV | |
Naoki Yoda | Vice President, Director (Department of Business Planning Liaison) | |
Tsuyoshi Nakamura | Vice President, Director (Finance and Accounting Department) and Otsuka Holdings | |
Yoshihiro Yoshinaga | Vice President, Director (Regulatory Affairs Department) and Administration Department | |
Hiroki Nakayama | Vice President, Director (Audit Department) and Otsuka Holdings |
Pharmaceutical Business Division
Lyo Inuyama | Executive Vice President, Director (Medical Affairs) |
---|---|
Keiso Yamasaki | Senior Vice President, Associate General Manager (Pharmaceutical Business Division), and Pharmaceutical Planning Department |
Hiroaki Ono | Senior Vice President, General Manager (Headquarters of Clinical Development) and Regulatory Affairs |
Akio Oikawa | Senior Vice President, General Manager (Pharmaceutical Business Headquarters) |
Nobuyuki Kurahashi | Senior Vice President, Seconded to Otsuka Pharmaceutical D&C Inc. |
Chikako Usami | Vice President, Pharmaceutical Business Division Project Coordinator |
Takayuki Shiratsuchi | Vice President, Medical Discovery & Development Data Analyst (MD Analyst) |
Nutraceuticals Division
Naoshi Satou | Senior Vice President, Associate General Manager (Nutraceuticals Division), Director (Social Health Relations Department) and Director (Promotion Advertisement) |
---|---|
Chiaki Sakurai | Senior Vice President, Associate General Manager (Nutraceuticals Division), Sales Headquarters, Cosmedics Department and Otsuka Holdings |
Shouzou Yamazaki | Senior Vice President, Director (Sales Development Department) |
Taro Mikuriya | Senior Vice President, Seconded to Nardobel SAS |
Tomonari Kawakami | Vice President, Director (Business Planning, Market Research & Education) |
Tomitsugu Nakabayashi | Vice President, Next-Generation Nutraceuticals Business Solution |
Koichiro Nitta | Vice President, Relational Marketing |
Otsuka International Asia Arab Division
Ryousuke Fukase | Vice President, Nutraceuticals Business |
---|---|
Yoshihiro Bando | Vice President, New Area Development |
Productions
Toshihiro Tokumoto | Senior Vice President, Tokushima Headquarters, Purchasing and Otsuka Holdings |
---|---|
Ryo Harima | Vice President, Deputy General Manager (Production) |
Junichi Jinno | Vice President, General Manager (CMC) |
Headquarters
Kenji Bunya | Senior Vice President, Director (Human Resources Department), Public Relations and Legal Affairs |
---|---|
Junichi Hashimoto | Vice President, Director (Compliance), PV |
Naoki Yoda | Vice President, Director (Department of Business Planning Liaison) |
Tsuyoshi Nakamura | Vice President, Director (Finance and Accounting Department) and Otsuka Holdings |
Yoshihiro Yoshinaga | Vice President, Director (Regulatory Affairs Department) and Administration Department |
Hiroki Nakayama | Vice President, Director (Audit Department) and Otsuka Holdings |
As of March 9, 2022